首页> 外文期刊>Molecular Biology >Inhibition of Calpain Expression by E-64d in the Rat Retina Subjected to Ischemia/Reperfusion Injury
【24h】

Inhibition of Calpain Expression by E-64d in the Rat Retina Subjected to Ischemia/Reperfusion Injury

机译:E-64d抑制缺血/再灌注损伤大鼠视网膜中钙蛋白酶的表达

获取原文
获取原文并翻译 | 示例

摘要

To investigate the effect of E-64d, a selective inhibitor of calpain, on the expression of calpain and calpastatin in rat retina was subjected to ischemia/reperfusion injury (IRI). An animal model of retinal IRI was set up by increasing the intraocular pressure (110 mm Hg) of a rat eye for 1 h. The retinal thickness and morphologic changes were detected by histology. The protein expression of m-calpain (a calpain isoform) in the retina was assessed by immunohistochemistry and Western blot assay. The mRNA of m-calpain, as well as calpastatin (an endogenous protein inhibitor of calpain), in the retina was assessed by RT-PCR, and the ratio of m-calpain/calpastatin was then calculated. To evaluate the effect of E-64d on the expression of calpain, the drug (5 μl of 100 μM) was injected intravitreously immediately after IRI. There were retinal edematous changes, particularly in the inner plexiform layer after IRI. The protein expression of m-calpain in the retina was increased 24 h after IRI, an effect that was inhibited by E-64d (P < 0.05). The mRNA expression of m-calpain and calpastatin was also increased 24 h and 3 h after IRI, respectively. Neither m-calpain nor calpastatin mRNA expression was influenced by E-64d (P > 0.05). The mRNA ratio of m-calpain to calpastatin was increased at the 6 h, 24 h and 72 h after IRI, and only at 24 h the increase of the ratio of m-calpain to calpastatin was inhibited by E-64d (P < 0.05). In the rat retina of IRI, E-64d inhibits the increase of m-calpain protein expression, as well as the mRNA ratio increase of m-calpain to calpastatin. E-64d also inhibited the retinal damage induced by IRI, suggesting a role for E-64d in the protection of the retinal apoptosis induced by IRI.
机译:为了研究钙蛋白酶的选择性抑制剂E-64d对大鼠视网膜缺血/再灌注损伤(IRI)中钙蛋白酶和钙蛋白酶抑素表达的影响。通过增加大鼠眼睛的眼内压(110 mm Hg)1小时来建立视网膜IRI动物模型。通过组织学检测视网膜厚度和形态变化。通过免疫组织化学和蛋白质印迹分析评估了m-钙蛋白酶(一种钙蛋白酶同工型)在视网膜中的蛋白表达。通过RT-PCR评估视网膜中m-钙蛋白酶的mRNA以及calpastatin(钙蛋白酶的内源性蛋白抑制剂)的含量,然后计算m-钙蛋白酶/钙蛋白酶抑素的比例。为了评估E-64d对钙蛋白酶表达的影响,在IRI后立即玻璃体内注射药物(5μl,100μM)。有视网膜水肿变化,尤其是IRI后的内丛状层。 IRI后24小时视网膜中m-钙蛋白酶的蛋白表达增加,这一作用被E-64d抑制(P <0.05)。 IRI后24小时和3小时m-钙蛋白酶和钙抑素的mRNA表达也分别升高。 E-64d既不影响m-calpain也不影响calpastatin mRNA的表达(P> 0.05)。在IRI后6小时,24小时和72小时,m-钙蛋白酶与钙蛋白酶的mRNA比率增加,并且仅在24 h时,E-64d抑制m-钙蛋白酶与钙蛋白酶的比率的增加(P <0.05 )。在IRI的大鼠视网膜中,E-64d抑制m-钙蛋白酶蛋白表达的增加,以及m-钙蛋白酶与钙蛋白酶的mRNA比率的增加。 E-64d还抑制了IRI诱导的视网膜损伤,提示E-64d在保护IRI诱导的视网膜凋亡中具有作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号